心脏骤停中的COVID-19与施救者感染风险:系统评价
该系统评价针对心脏骤停施救者COVID-19传播风险,于2020年3月24日检索MEDLINE、Embase、Cochrane Central Register of Controlled Trials和世界卫生组织COVID-19数据库,纳入11项研究(2项队列研究、1项病例对照研究、5项病例报告、3项模拟人随机对照试验),评估三个问题:关键干预(胸外按压、除颤、心肺复苏)的气溶胶生成、空气传播感染风险及不同个人防护装备策略的效果。未发现任何直接证据表明胸外按压或除颤与气溶胶生成或感染传播相关或不相关;模拟人研究提示穿戴个人防护装备会延迟治疗实施。所有研究均为间接证据,无研究描述COVID-19患者,所有结局证据确定性为低或极低。结论为胸外按压或除颤是否导致气溶胶生成或传播COVID-19尚不确定,证据非常有限,急需进一步研究。
要点
- 未发现直接证据表明胸外按压或除颤与气溶胶生成或感染传播相关或不相关。
- 模拟人研究提示穿戴个人防护装备会延迟治疗实施。
- 所有研究均为间接证据,无研究描述COVID-19患者。
- 所有结局证据确定性为低或极低。
- 胸外按压或除颤是否导致气溶胶生成或传播COVID-19尚不确定,证据非常有限,急需进一步研究。
研究设计与关键结果
- 研究类型为系统评价,纳入11项研究:2项队列研究、1项病例对照研究、5项病例报告、3项模拟人随机对照试验。
- 检索MEDLINE、Embase、Cochrane Central Register of Controlled Trials和世界卫生组织COVID-19数据库,检索日期为2020年3月24日,系统评价注册号PROSPERO CRD42020175594。
- 未发现任何直接证据表明胸外按压或除颤与气溶胶生成或感染传播相关或不相关。
- 模拟人研究提示穿戴个人防护装备会延迟治疗实施。
- 所有研究均为间接证据,无研究描述COVID-19患者,所有结局证据确定性为低或极低。
证据类型、等级与局限
- 证据类型:系统评价,纳入2项队列研究、1项病例对照研究、5项病例报告、3项模拟人随机对照试验。
- 采用GRADE过程评估证据确定性,所有结局证据确定性为低或极低。
- 局限:所有研究均为间接证据,无研究描述COVID-19患者;证据非常有限,急需进一步研究。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There may be a risk of COVID-19 transmission to rescuers delivering treatment for cardiac arrest. The aim of this review was to identify the potential risk of transmission associated with key interventions (chest compressions, defibrillation, cardiopulmonary resuscitation) to inform international treatment recommendations.
METHODS: We undertook a systematic review comprising three questions: (1) aerosol generation associated with key interventions; (2) risk of airborne infection transmission associated with key interventions; and (3) the effect of different personal protective equipment strategies. We searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and the World Health Organization COVID-19 database on 24th March 2020. Eligibility criteria were developed individually for each question. We assessed risk of bias for individual studies, and used the GRADE process to assess evidence certainty by outcome.
RESULTS: We included eleven studies: two cohort studies, one case control study, five case reports, and three manikin randomised controlled trials. We did not find any direct evidence that chest compressions or defibrillation either are or are not associated with aerosol generation or transmission of infection. Data from manikin studies indicates that donning of personal protective equipment delays treatment delivery. Studies provided only indirect evidence, with no study describing patients with COVID-19. Evidence certainty was low or very low for all outcomes.
CONCLUSION: It is uncertain whether chest compressions or defibrillation cause aerosol generation or transmission of COVID-19 to rescuers. There is very limited evidence and a rapid need for further studies. Review registration: PROSPERO CRD42020175594.
参考来源
- Couper K, Taylor-Phillips S, Grove A, et al. COVID-19 in cardiac arrest and infection risk to rescuers: A systematic review. Resuscitation. 2020. PMID: 32325096. doi:10.1016/j.resuscitation.2020.04.022
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。